Emotion Awareness and Skills Enhancement Program



Status:Recruiting
Conditions:Neurology, Autism
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:12 - 21
Updated:10/18/2018
Start Date:January 30, 2018
End Date:June 30, 2023
Contact:Carla A Mazefsky, Ph.D
Email:mazefskyca@upmc.edu
Phone:412-246-5459

Use our guide to learn which trials are right for you!

Emotion Awareness and Skills Enhancement (EASE) Program: A Clinical Trial

This project will address impaired emotion regulation in adolescents with ASD (autism
spectrum disorder). There are no evidence-based interventions to improve emotion regulation
(ER) in this population, yet poor emotion regulation often leads to maladaptive behavior and
substantially impedes capacity to learn and function across all life settings, and reduce
their quality of life and that of their families. The primary objective of this study is to
formally evaluate efficacy of EASE via a sufficiently powered, two-site randomized-controlled
trial (RCT).

The current study is to test a new intervention called Emotional Awareness and Skills
Enhancement (EASE). This program was designed to address ASD-specific obstacles to effective
emotion regulation, such as reduced awareness concerning others' intentions, a limited
repertoire of behavioral responses, and inadequate language for understanding emotional
experiences. This new program is based on an acceptance-based approach in which awareness of
emotion is developed, emotions (whether negative or positive) are accepted, and behavior is
regulated in the face of intense emotion. The goal is not to learn to avoid negative
emotions, but rather to develop a collection of abilities which allow the individual to
manage stress and act in ways that are more adaptive. The investigators expect to find that
participants' emotion dysregulation will decrease and their adaptive function will increase
following completion of the EASE program.

Inclusion Criteria:

1. ages 12-21 years, inclusive

2. A diagnosis of ASD (autism spectrum disorder), as defined by exceeding the ASD cutoff
on the ADOS-2 (Autism Diagnostic Observation Scale) or ADI-R (Autism Diagnostic
Interview-Revised) In. If the participant has completed the ADOS in a previous study
within 3 years and signs a release of information to obtain it, they will not be
required to complete another ADOS.

3. Average verbal intellectual ability (Wechsler Abbreviated Scale of Intelligence-2
[WASI-2] Verbal Intelligence Quotient>80).

4. Fluent in the English language

5. Problems with regulating emotions based on parent report 6) Parent/guardian who will
attend sessions and assessments.

Exclusion Criteria:

1. Current concerns of suicidality that warrants immediate clinical care (such potential
participants will be referred elsewhere for treatment), determined by clinical
interview.

2. Previous or current diagnosis of a psychotic disorder.

3. Receiving concurrent psychotherapy treatment for emotional issues (i.e., depression,
anxiety, anger) that overlaps with the current study. This will be assessed using
current treatment items on the demographic forms.
We found this trial at
2
sites
Tuscaloosa, Alabama 35401
Principal Investigator: Susan White, PhD
Phone: 205-348-3535
?
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15261
Principal Investigator: Carla Mazefsky, PhD
Phone: 412-246-5459
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials